News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Drug Development
Takeda Pharmaceutical Co. Ltd. (Jobs) Drops Development of Actos Combination Drug
June 1, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
TOKYO, June 1 (Reuters) - Takeda Pharmaceutical Co. Ltd., Japan's biggest drug maker, has dropped development of a medicine that combined its diabetes drug Actos and a drug candidate that controls high blood pressure.
Twitter
LinkedIn
Facebook
Email
Print
Clinical research
Phase III
Asia
MORE ON THIS TOPIC
Friedreich’s ataxia
Larimar’s Friedreich’s Ataxia Drug Troubled by Anaphylaxis Concerns; Shares Fall
September 30, 2025
·
2 min read
·
Tristan Manalac
Rare diseases
New Confirmatory Study Hints at ‘Alignment’ Between Applied Therapeutics, FDA for Rare Disease Drug
September 29, 2025
·
2 min read
·
Tristan Manalac
Immunology and inflammation
Hansa Kidney Transplant Drug Aces Phase III Study, Headed to FDA
September 26, 2025
·
2 min read
·
Tristan Manalac
Pancreatic cancer
Immuneering Asset Nearly Doubles Overall Survival in Pancreatic Cancer After 9 Months
September 25, 2025
·
2 min read
·
Tristan Manalac
